Effects of in vivo treatment with diphenyl ditelluride on the phosphorylation of cytoskeletal proteins in cerebral cortex and hippocampus of rats

NeuroToxicology

Volumn 29, Issue 1, 2008, Pages 40-47

  Heimfarth, Luana ^a   Loureiro, Samanta Oliveira ^a   Zamoner, Ariane ^a   Pelaez, Priscila de Lima ^a   Nogueira, Cristina Wayne ^b   Rocha, João Batista Teixeira da ^b   Pessoa Pureur, Regina ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Cytoskeleton; Intermediate filaments; Organochalcogen compounds; Protein phosphorylation

Indexed keywords

BIPHENYL DERIVATIVE; CYTOSKELETON PROTEIN; DIPHENYL DITELLURIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; HIPPOCAMPUS; IN VIVO STUDY; INTERMEDIATE FILAMENT; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84984573022     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2007.08.012     Document Type: Article

References (48)

1. Abd-Elghaffar S.Kh., El-Sokkary G.H., and Sharkawy A.A. Aluminium-induced neurotoxicity and oxidative damage in rabbits: protective effect of melatonin. Neuro Endocrinol Lett 26 (2005) 609-616
2. Ackerley S., Grierson A.J., Brownlees J., Thornhiel P., Anderton B.H., Leight P.N., et al. Glutamate slow axonal transport of neurofilaments in transfected neurons. J Cell Biol 150 (2000) 165-175
3. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter P. The cytoskeleton. In: Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter P. (Eds). Molecular biology of the cell (2002), Garland Science, New York 907-982
4. Benítez-King G. PKC activation by melatonin modulates vimentin intermediate filament organization in N1E-115 cells. J Pineal Res 29 (2000) 8-14
5. Benítez-King G. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 40 (2006) 1-9
6. Briones T.L., Woods J., Wadowska M., Rogozinska M., and Nguyen M. Astrocytic changes in the hippocampus and functional recovery after cerebral ischemia are facilited by rehabilitation training. Behav Brain Res 171 (2006) 17-25
7. Dewaegh S.M., Lee V.M.Y., and Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal-transport by myelinating Schwann-cells. Cell 68 (1992) 451-463
8. Diprospero N.A., Chen E.-Y., Charles V., Plomann M., Kordower J.H., and Tangle D.A. Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements. J Neurocytol 33 (2004) 517-533
9. Eng L.F., Ghirnikar R.S., and Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25 (2000) 1439-1451
10. Funchal C., de Lima Pelaez P., Oliveira Loureiro S., Vivian L., Dall Bello Pessutto F., de Almeida L.M.V., et al. α-Ketoisocaproic acid regulates phosphorylation of intermediate filaments in postnatal rat cortical slices through ionotropic glutamatergic receptors. Dev Brain Res 139 (2002) 267-276
11. Funchal C., de Almeida L.M., Oliveira Loureiro S., Vivian L., de Lima Pelaez P., Dall Bello Pessutto F., et al. In vitro phosphorylation of cytoskeletal proteins from cerebral cortex of rats. Brain Res Prot 11 (2003) 111-118
12. Funchal C., Quincozes dos Santos A., Jacques-Silva M.C., Zamoner A., Gottfried C., Wajner M., et al. Branched-chain α-keto acids accumulating in maple syrup urine disease induce reorganization of phosphorylated GFAP in C6 glioma cells. Metab Brain Dis 20 (2005) 205-219
13. Funchal C., Moretto M.B., Vivian L., Zeni G., Rocha J.B.T., and Pessoa-Pureur R. Diphenyl ditelluride- and methylmercury-induced hyperphosphorylation of the high molecular weight neurofilament subunit is prevented by organoselenium compounds in cerebral cortex of young rats. Toxicology 222 (2006) 143-153
14. Goedert M., Spillantini M.G., and Davies S.W. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 8 (1998) 619-632
15. Gotow T., Tanaka T., Nakamura Y., and Takeda M. Dephosphorylation of the largest neurofilament subunit protein influences the structure of crossbridges in reassembled neurofilaments. J Cell Sci 107 (1994) 1949-1957
16. Grant P., and Pant H.C. Neurofilament protein synthesis and phosphorylation. J Neurocytol 29 (2000) 843-872
17. Haller W.S., and Irgolic K.J. Diaryl ditellurides from Grignard-reagents and elemental tellurium. J Organomet Chem 38 (1972) 97-103
18. Hashimoto R., Nakamura Y., Goto H., Wada Y., Sakoda S., and Kaibuchi K. Domain- and site-specific phosphorylation of bovine NF-L by Rho-associated kinase. Biochem Biophys Res Commun 245 (1998) 407-411
19. Hsieh S.T., Kidd G.J., Crawforg T.O., Xu Z., Lin W.M., Trapp B.D., et al. Regional modulation of neurofilament organization by myelination in normal axons. J Neurosci 14 (1994) 6392-6401
20. Inada H., Goto H., Tanabe K., Nishi Y., Kaibuchi K., and Inagaki M. Rho-associated kinase phosphorylates desmin, the myogenic intermediate filament protein, at unique amino-terminal sites. Biochem Biophys Res Commun 253 (1998) 21-25
21. Inagaki M., Nishi Y., Nishizawa K., Matsuyama M., and Sato C. Site-specific phosphorylation induces disassembly of vimentin filaments in vitro. Nature 328 (1987) 649-652
22. Inagaki M., Gonda Y., Nishizawa K., Kitamura S., Sato C., and Ando S. Phosphorylation sites linked to glial filament disassembly in vitro located in a non-alpha-helical head domain. J Biol Chem 265 (1990) 4722-4729
23. Inagaki N., Tsujimura K., Tanaka J., Sekimata M., Kamei Y., and Inagaki M. Visualization of protein kinase activities in single cells by antibodies against phosphorylated vimentin and GFAP. Neurochem Res 21 (1996) 795-800
24. Julien J.P. Neurofilament functions in health and disease. Curr Opin Neurobiol 9 (1999) 554-560
25. Julien J.P., and Mushynski W.E. Neurofilaments in health and disease. Prog Nucl Acid Res Mol Biol 61 (1998) 1-23
26. Ku N.O., and Omary M.B. Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431. J Biol Chem 272 (1997) 7556-7564
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277 (1970) 680-685
28. Leterrier J.F., Kas J., Hartwig J., Vegners R., and Janmey P.A. Mechanical effects of neurofilament cross-bridges. Modulation by phosphorylation, lipids, and interactions with F-actin. J Biol Chem 271 (1996) 15687-15694
29. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 93 (1951) 265-267
30. Moretto M.B., Funchal C., Zeni G., Pessoa-Pureur R., and Rocha J.B.T. Selenium compounds prevent the effects of methylmercury on the in vitro phosphorylation of cytoskeletal proteins in cerebral cortex of young rats. Toxicol Sci 85 (2005) 639-646
31. Moretto M.B., Funchal C., Zeni G., Rocha J.B.T., and Pessoa-Pureur R. Organoselenium compounds prevent hyperphosphorylation of cytoskeletal proteins induced by the neurotoxic agent diphenyl ditelluride in cerebral cortex of young rats. Toxicology 210 (2005) 213-222
32. Nixon R.A., and Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci 14 (1991) 501-506
33. Nguyen M.D., Lariviere R.C., and Julien J.P. D of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30 (2001) 135-147
34. Nogueira C.W., Zeni G., and Rocha J.B. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev 104 (2004) 6255-6285
35. Paramio J.M., and Jorcano J.L. Beyond structure: do intermediate filaments modulate cell signalling?. Bioessays 24 (2002) 836-844
36. Paulmier C. Selenium reagents and intermediates in organic synthesis (1986), Pergamon Press, New York p. 463
37. Pearson R.G., Sobel H., and Songstad J. Nucleophilic reactivity constants toward methyl iodide and trans-[PT(PY)2CL2]. J Am Chem Soc 90 (1968) 319-326
38. Peter M., Sanghera J.S., Pelech S.S., and Nigg E.A. Mitogen-activated protein kinases phosphorylate nuclear lamins and display sequence specificity overlapping that of mitotic protein kinase p34 cdc2. Eur J Biochem 205 (1992) 287-294
39. Petragnami N. Preparation of the principal classes of organic tellurium compounds. In: Katritzky A.R., Meth-Cohn O., and Rees C.W. (Eds). Tellurium in Organic Synthesis (1994), London: Academic Press pp. 9-88
40. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233 (2005) 83-198
41. Pollenz R.S., and McCarthy K.D. Analysis of cyclic AMP-dependent changes in intermediate filament protein phosphorylation and cell morphology in cultured astroglia. J Neurochem 47 (1986) 9-17
42. Sihag R.K., and Nixon R.A. Phosphorylation of the amino terminal head domain of the middle molecular mass 145 kDa subunit of neurofilaments. J Biol Chem 265 (1990) 4166-4171
43. Stangherlin E.U., Favero A.M., Weis S.N., Zeni G., Rocha J.B.T., and Nogueira C. Teratogenic vulnerability of rat fetuses to diphenyl ditelluride: prenatal assessment. Toxicology 207 (2005) 231-239
44. Stangherlin E.C., Favero A.M., Zeni G., Rocha J.B.T., and Nogueira C.W. Exposure of mothers to diphenyl ditelluride during the suckling period changes behavioral tendencies in their offspring. Brain Res Bull 69 (2006) 311-317
45. Stangherlin E.U., Favero A.M., Weis S.N., Zeni G., Rocha J.B.T., and Nogueira C.W. Assessment of reproductive toxicity in male rats following acute and sub-chronic exposures to diphenyl diselenide and diphenyl ditelluride. Food Chem Toxicol 44 (2006) 662-669
46. Tanaka J., Ogawara M., Ando S., Shibata M., Yatani R., and Kusagawa M. Phosphorylation of a 62 kd porcine alpha-internexin, a newly identified intermediate filament protein. Biochem Biophys Res Commun 196 (1993) 115-123
47. Walbran B.B., and Robins E. Effects of central nervous system accumulation of tellurium on behavior in rats. Pharmacol Biochem Behav 9 (1978) 297-300
48. Widy-Tyszkiewicz E., Piechal A., Gajkowska B., and Smialek M. Tellurium-induced cognitive deficits in rats are related to neuropathological changes in the central nervous system. Toxicol Lett 131 (2002) 203-214